Bone cement/layered double hydroxide nanocomposites as potential biomaterials for joint implant
Source abstract
Abstract
Abstract Poly(methyl methacrylate)‐based bone cement and layered double hydroxide (LDH) nanocomposites have been used as a grouting material for total joint arthroplasty. Few weight percentage of nanoLDH was uniformly dispersed in the bone cement matrix to have adequate interaction with matrix polymer. Mechanical strength, stiffness, toughness, and fatigue resistance of the nanocomposites are found to be higher than that of pure bone cement. Nanocomposites are thermally stable as compared to pristine bone cement. Direct mixing of the nanoLDH without any organic solvent makes these nanocomposites biocompatible. Biocompatibility was evaluated and compared with that of commercial bone cement by measuring hydrophilic nature, hemolysis assay, thrombosis assay, and deposition of apatite in simulated body fluid immersion. Finally, the viability of human osteoblast cells on the above developed nanocomposites was testified for actual biocompatibility. The experiment showed better cell growth in nanocomposites as compared to pure bone cement. Thus, these nanocomposites are found to be better grouting material than bone cement. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A:3363–3373, 2012.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · Bone Tissue Engineering Materials · Magnesium Oxide Properties and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (53)
Show source-provided references
1. Anchorahe of the femoral head prosthesis to the shaft of the femur10.1302/0301-620X.42B1.28 ↗
2. Stanmore compared with Charnley total hip replacement: A prospective study of 413 arthroplasties10.1302/0301-620X.78B2.0780178 ↗
3. Cement migration after THR. A comparison of Charnley Elite and Exeter femoral stems using RSAJ10.1302/0301-620X.81B1.0810130 ↗
4. 10.2106/00004623-199509000-0000410.2106/00004623-199509000-00004 ↗
5. Total hip arthroplasty with cement in patients who are less than fifty years old‐a sixteen to twenty‐two‐year follow‐up study10.2106/00004623-199406000-00010 ↗
6. 10.1016/S1350-4533(03)00120-610.1016/S1350-4533(03)00120-6 ↗
7. 10.1023/A:102292781480110.1023/A:1022927814801 ↗
8. 10.2106/00004623-199072080-0001510.2106/00004623-199072080-00015 ↗
9. The Initiation of failure in cemented femoral components of hip arthroplasties10.1302/0301-620X.73B4.2071634 ↗
10. 10.1002/jbm.82024020210.1002/jbm.820240202 ↗
11. 10.1016/0267-6605(93)90056-D10.1016/0267-6605(93)90056-D ↗
12. 10.1016/j.mseb.2009.10.01710.1016/j.mseb.2009.10.017 ↗
13. 10.1007/s10856-008-3465-710.1007/s10856-008-3465-7 ↗
14. 10.1007/s10856-006-9685-910.1007/s10856-006-9685-9 ↗
15. 10.1002/app.3371210.1002/app.33712 ↗
16. 10.1016/j.biomaterials.2006.03.00210.1016/j.biomaterials.2006.03.002 ↗
17. 10.1016/j.biomaterials.2004.10.04210.1016/j.biomaterials.2004.10.042 ↗
18. 10.1016/S0142-9612(02)00354-X10.1016/S0142-9612(02)00354-X ↗
19. Elastic and ultimate properties of acrylic bone cement reinforced with ultra high molecular weight polyethylene fibres
20. 10.1002/(SICI)1097-4636(1999)48:2<135::AID-JBM7>3.0.CO;2-610.1002/(SICI)1097-4636(1999)48:2<135::AID-JBM7>3.0.CO;2-6 ↗
21. 10.1002/jbm.82017061310.1002/jbm.820170613 ↗
22. 10.1002/(SICI)1097-4636(200008)51:2<258::AID-JBM15>3.0.CO;2-S10.1002/(SICI)1097-4636(200008)51:2<258::AID-JBM15>3.0.CO;2-S ↗
23. 10.1016/S0142-9612(02)00354-X10.1016/S0142-9612(02)00354-X ↗
24. 10.1007/s10856-006-0616-610.1007/s10856-006-0616-6 ↗
25. 10.1016/S0142-9612(97)00117-810.1016/S0142-9612(97)00117-8 ↗
26. 10.1002/1097-4636(2000)53:6<717::AID-JBM15>3.0.CO;2-H10.1002/1097-4636(2000)53:6<717::AID-JBM15>3.0.CO;2-H ↗
27. 10.1007/BF0236307310.1007/BF02363073 ↗
28. 10.1016/0920-5861(91)80068-K10.1016/0920-5861(91)80068-K ↗
29. 10.1039/b008680k10.1039/b008680k ↗
30. 10.1016/j.clay.2006.07.00710.1016/j.clay.2006.07.007 ↗
31. 10.1163/15685620074382310.1163/156856200743823 ↗
32. 10.1371/journal.pone.001709310.1371/journal.pone.0017093 ↗
33. 10.1016/j.clay.2007.05.01110.1016/j.clay.2007.05.011 ↗
34. 10.1021/cm020370h10.1021/cm020370h ↗
35. 10.1016/S0924-2031(02)00049-810.1016/S0924-2031(02)00049-8 ↗
36. 10.1002/jrs.124410.1002/jrs.1244 ↗
37. 10.1351/PAC-CON-08-07-0110.1351/PAC-CON-08-07-01 ↗
38. 10.1016/0141-3910(96)00022-510.1016/0141-3910(96)00022-5 ↗
39. 10.1016/j.actbio.2008.07.01210.1016/j.actbio.2008.07.012 ↗
40. 10.1002/pol.1965.10003072110.1002/pol.1965.100030721 ↗
41. 10.1007/BF0015455310.1007/BF00154553 ↗
42. 10.1016/S0927-7765(99)00158-710.1016/S0927-7765(99)00158-7 ↗
43. 10.1007/s289-001-8183-910.1007/s289-001-8183-9 ↗
44. 10.1002/(SICI)1097-0304(199611)39:3<287::AID-CCD17>3.0.CO;2-C10.1002/(SICI)1097-0304(199611)39:3<287::AID-CCD17>3.0.CO;2-C ↗
45. 10.1007/978-1-4684-7744-3_1410.1007/978-1-4684-7744-3_14 ↗
46. 10.1016/S0003-9969(03)00007-410.1016/S0003-9969(03)00007-4 ↗
47. Degrees of saturation with respect to apatites in parotid saliva at various pH values
48. Gamble JE · 1967 · 17
49. 10.1002/jbm.82024060710.1002/jbm.820240607 ↗
50. 10.2109/jcersj.99.96510.2109/jcersj.99.965 ↗
51. 10.2109/jcersj.109.1268_S4910.2109/jcersj.109.1268_S49 ↗
52. 10.1016/j.biomaterials.2006.01.01710.1016/j.biomaterials.2006.01.017 ↗
53. 10.1016/0371-1951(66)80133-910.1016/0371-1951(66)80133-9 ↗